Successful diagnosis of attention deficit hyperactivity disorder in later life of an adult with intellectual disability: A case report

被引:1
作者
Raji, Oyepeju [1 ]
Javaid, Shafaq [1 ]
机构
[1] South West London & St Georges MH NHS Trust, Springfield Univ Hosp, Psychiat Intellectual Disabil, London SW17 7DJ, England
关键词
attention deficit hyperactivity disorder (ADHD); autism spectrum disorder (ASD); diagnosis; intellectual disability; Lisdexamfetamine; long acting stimulant; DEFICIT/HYPERACTIVITY DISORDER; EMOTIONAL LABILITY; ADHD; COMORBIDITY; PREVALENCE; PEOPLE; ATOMOXETINE; MANAGEMENT; CHILDREN; ADOLESCENTS;
D O I
10.1111/bld.12446
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background Diagnosing and managing attention deficit hyperactivity disorder in adults with intellectual disabilities is currently largely based on findings from assessment and treatment in children or adults without intellectual disabilities. Current evidence suggests that individuals with intellectual disabilities are more likely to have attention deficit hyperactivity disorder compared to those without intellectual disabilities, but more research is needed. There is increasing knowledge of diagnosing and treating attention deficit hyperactivity disorder in people with intellectual disabilities with published guidance on delivering care based on good evidence. More is needed so that clinicians do not have to depend on the evidence from those who do not have intellectual disabilities. Method To write this report, we reviewed a female in her 50s with mild intellectual disability who has been known to general and specialist intellectual disability mental health services for at least 20 years over many episodes of care. We assessed her clinically and using the Diagnostic Interview for attention deficit hyperactivity disorder in Adults with intellectual disabilities to make a diagnosis of attention deficit hyperactivity disorder. We call her Mary, which is not her real name. Findings Mary has had many diagnoses however, we found that her neurodevelopmental disorders of attention deficit hyperactivity disorder and we believe, autism were missed which led to a complex presentation of behavioural and mental symptoms; and diagnostic and management challenges. Mary was receiving combinations of medications known as antipsychotics, antidepressants, hypnotics and mood stabilisers to high doses. She was able to stop them all successfully over 12-18 months before being diagnosed with attention deficit hyperactivity disorder. Once diagnosed with attention deficit hyperactivity disorder, Mary rapidly responded to a long acting stimulant as recommended by the National Institute for Health and Care Excellence and this has significantly improved her quality of life. Conclusion Attention deficit hyperactivity disorder in people with intellectual disabilities is often missed and inadequately managed, despite having highly effective and specific treatment strategies. Making the diagnoses of attention deficit hyperactivity disorder and intellectual disabilities is important as individuals with both together have worse outcomes. Therefore, effective treatment of attention deficit hyperactivity disorder in individuals with intellectual disabilities is critical.
引用
收藏
页码:578 / 585
页数:8
相关论文
共 46 条
[11]   RETRACTED: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults (Retracted Article) [J].
Epstein, Tamir ;
Patsopoulos, Nikolaos A. ;
Weiser, Mark .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09)
[12]   Attention-deficit/hyperactivity disorder [J].
Faraone, Stephen V. ;
Asherson, Philip ;
Banaschewski, Tobias ;
Biederman, Joseph ;
Buitelaar, Jan K. ;
Ramos-Quiroga, Josep Antoni ;
Rohde, Luis Augusto ;
Sonuga-Barke, Edmund J. S. ;
Tannock, Rosemary ;
Franke, Barbara .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[13]   Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis [J].
Faraone, Stephen V. ;
Buitelaar, Jan .
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2010, 19 (04) :353-364
[14]   Atomoxetine for Attention Deficit Hyperactivity Disorder in Mental Retardation [J].
Fernandez-Jaen, Alberto ;
Martin Fernandez-Mayoralas, Daniel ;
Calleja Perez, Beatriz ;
Munoz Jareno, Nuria ;
Campos Diaz, Maria del Rosario .
PEDIATRIC NEUROLOGY, 2010, 43 (05) :341-347
[15]   Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan [J].
Franke, Barbara ;
Michelini, Giorgia ;
Asherson, Philip ;
Banaschewski, Tobias ;
Bilbow, Andrea ;
Buitelaar, Jan K. ;
Cormand, Bru ;
Faraone, Stephen V. ;
Ginsberg, Ylva ;
Haavik, Jan ;
Kuntsi, Jonna ;
Larsson, Henrik ;
Lesch, Klaus-Peter ;
Antoni Ramos-Quiroga, J. ;
Rethelyi, Janos M. ;
Ribases, Marta ;
Reif, Andreas .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (10) :1059-1088
[16]   Predicted effect size of lisdexamfetamine treatment of attention deficit/hyperactivity disorder (ADHD) in European adults: Estimates based on indirect analysis using a systematic review and meta-regression analysis [J].
Fridman, M. ;
Hodgkins, P. S. ;
Kahle, J. S. ;
Erder, M. H. .
EUROPEAN PSYCHIATRY, 2015, 30 (04) :521-527
[17]   The familial co-aggregation of ASD and ADHD: a register-based cohort study [J].
Ghirardi, L. ;
Brikell, I. ;
Kuja-Halkola, R. ;
Freitag, C. M. ;
Franke, B. ;
Asherson, P. ;
Lichtenstein, P. ;
Larsson, H. .
MOLECULAR PSYCHIATRY, 2018, 23 (02) :257-262
[18]   Changing ASD-ADHD symptom co-occurrence across the lifespan with adolescence as crucial time window: Illustrating the need to go beyond childhood [J].
Hartman, Catharina A. ;
Geurts, Hilde M. ;
Franke, Barbara ;
Buitelaar, Jan K. ;
Rommelse, Nanda N. J. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 71 :529-541
[19]  
Knouse Laura E, 2008, Expert Rev Neurother, V8, P1537, DOI 10.1586/14737175.8.10.1537
[20]   Distinguishing Comorbidity and Successful Management of Adult ADHD [J].
Kooij, J. J. Sandra ;
Huss, Michael ;
Asherson, Philip ;
Akehurst, Ron ;
Beusteriens, Kathleen ;
French, Alexis ;
Sasane, Rahul ;
Hodgkins, Paul .
JOURNAL OF ATTENTION DISORDERS, 2012, 16 (05) :3S-19S